Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep319 | Clinical case reports - Thyroid/Others | ECE2017

Congenital fibrous dysplasia and Klinefelter syndrome: coincidence or not?

Grama Maria Alexandra , Dumitrache Constantin

Congenital fibrous dysplasia is a rare disease with a broad spectrum of manifestations, including various endocrinopathies;precocious puberty, hyperthyroidism, excess growth hormone, hypophosphatemia mediated by FGF23.We present the case of a 33 year old male, who presented in our endocrinology service with infertility and bone pain. He was diagnosed at the age of years old with congenital fibrous dyplasia and suffered multiple surgeries for bone decompr...

ea0029p440 | Clinical case reports - Thyroid/Others | ICEECE2012

Association between diabetes mellitus and sarcoidosis: a case report

Bulgar A. , Brehar A. , Paun D. , Cojocaru A. , Dumitrache C.

Introduction: Sarcoidosis is a multisystemic inflammatory disease of unknown etiology, characterized by noncaseating granulomas, predominantly in the lymph nodes, lungs, eyes and skin, although any organ may be involved.Sarcoidosis may also be associated with endocrine autoimmune diseases such as type 1 diabetes, autoimmune thyroiditis.Case report: We present a case of a 24-year-old young man who was diagnosed in August 2010 with t...

ea0022p441 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Metastatic mammary carcinomas with neuroendocrine features- a case report

Brehar Andreea , Bulgar Alexandra , Dumitrache Constantin

Mammary carcinomas with endocrine differentiation are an uncommon subtype of breast carcinomas that are morphologically indistinguishable from low-grade endocrine neoplasm arising in other organs.Neuroendocrine cells are present in mammary tissue. Neuroendocrine differentiation can be found in benign and malign lesions of various organs. Recent studies have reported the existence of neuroendocrine differentiation in breast carcinomas as being between 3% ...

ea0026p110 | Female reproduction | ECE2011

MTHFR mutations in female patients with autoimmune thyroiditis

Bulgar Alexandra , Brehar Andreea , Paun Diana , Dumitrache Constantin

Introduction: Methylenetetrahydrofolate reductase (MTHFR) is a key regulatory enzyme involved in folate and homocysteine metabolism. The enzyme is encoded by a gene located on chromosome 1p36.3. MTHFR mutations frequently met in the population are C667T and A1298C. The impairment of homocysteine metabolism due to MTHFR gene polymorphism influences the risk for diseases such as CVS diseases, certain types of cancer and is associated with certain complications of pregnancy inclu...

ea0022p76 | Bone/Calcium | ECE2010

Osteomalacia: important cause of bone loss in a patient with inflamatory bowl disease: case report

Ghemigian Adina , Popescu Irina , Petrova Evghenia , Neacsu Elena , Dumitrache Constantin

Bone densitometry (DEXA) is the best method available today for diagnosing low bone density. However, DEXA is not able to differentiate osteoporosis from osteomalacia. The definitive diagnosis of osteomalacia is made by bone biopsy – rarely used in medical practice – which shows excess unmineralized bone. Tests of blood and urine may also be helpful: concentration of serum and urinary calcium and phosphorus, 25-hydroxyvitamin D and parathyroid hormone b...

ea0022p179 | Clinical case reports and clinical practice | ECE2010

Screening for nutritional status in the elderly

Popescu Irina , Ghemigian Adina , Petrova Evghenia , Dumitrache Constantin

The population of the world is aging and is estimated that by 2030 – 21% of global population will be aged 65 years and older. At present, under-nutrition in older people is a serious and growing global problem affecting even developed countries. As one ages, several physiological and pathlogical changes may contribute towards the development of protein energy malnutrition. This syndrom brings with it many adverse health outcomes and a significant cost to the individual, ...

ea0016p325 | Endocrine tumours | ECE2008

Mutations in the ret proto-oncogene in Romanian patients with multiple endocrine neoplasia type 2

Paun Diana , Duta Carmen , Mohora Maria , Dogaru Cristian , Dumitrache Constantin

Multiple endocrine neoplasia (MEN) is characterized by the occurrence of tumors involving two or more endocrine glands; MEN 2 is defined by medullary thyroid carcinoma in association with phaeochromocytoma and appears in several clinical variants, which may be inherited as autosomal dominant syndromes. Mutational analysis of RET protooncogene has been use in the diagnosis and management of patients and families with MEN 2 variants.Aim: In this study, we ...

ea0011p42 | Bone | ECE2006

The effect of once-weekly Risedronate on biochemical markers of bone turnover after three month of treatment

Paun D , Grigorie D , Ghemigian A , Cofaru F , Dumitrache C

The nitrogen-containing bisphosphonate Risedronate have been shown to reduce the risk of both spine and nonspine fractures by reducing bone turnover, increasing bone mass and improving bone strength.Objective: To study the effects of once-weekly Risedronate on bone turnover markers in osteoporotic patients after three month of treatment.Patients and methods: Study group included 50 osteoporotic patients (3 males and 47 females), me...

ea0011p46 | Bone | ECE2006

The effect of once-weekly Risedronate on biochemical markers of bone turnover after three month of treatment

Paun D , Grigorie D , Ghemigian A , Cofaru F , Dumitrache C

The nitrogen-containing bisphosphonate Risedronate have been shown to reduce the risk of both spine and nonspine fractures by reducing bone turnover, increasing bone mass and improving bone strength.Objective: To study the effects of once-weekly Risedronate on bone turnover markers in osteoporotic patients after three month of treatment.Patients and methods: Study group included 50 osteoporotic patients (3 males and 47 females), me...

ea0011p353 | Diabetes, metabolism and cardiovascular | ECE2006

The metabolic syndrome and insulin resistance in polycystic ovary syndrome – study over 40 patients

Neamtu C , Gherlan I , Boanta C , Caragheorgheopol A , Dumitrache C

Insulin resistance is possibly playing an underlying pathogenic role in the polycystic ovary syndrome (PCOS) and although is not a part of its definition, it appears in 50-90% of PCOS women. Polycystic ovary syndrome is also frequently associated with obesity; women suffering of PCOS seem to be at a great risk of developing a metabolic syndrome.Objectives: The aim of our study was to determine the prevalence of the metabolic syndrome in a population of 4...